
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 989 | 933 | 962 | 1063 | 1236 | 1848 |
Fund Return | -1.15% | -6.75% | -3.79% | 2.04% | 4.32% | 6.33% |
Place in category | 91 | 102 | 141 | 121 | 106 | 56 |
% in Category | 47 | 52 | 79 | 60 | 61 | 48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Hartford Dividend and Growth A | 4.83B | -1.48 | 6.88 | 9.80 | ||
Hartford Balanced Income A | 4.42B | 1.67 | 4.74 | 5.51 | ||
Hartford International Value I | 4.58B | 16.24 | 14.25 | 6.99 | ||
Hartford Capital Appreciation A | 4.42B | -7.91 | 7.79 | 8.68 | ||
Hartford Schroders International St | 4.44B | 8.68 | 9.24 | 7.15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 32.37B | 0.31 | 3.69 | 6.42 | ||
T. Rowe Price Health Sciences | 6.47B | -0.13 | 3.27 | 7.56 | ||
Fidelity Select Health Care | 6.2B | -2.20 | 4.18 | 7.04 | ||
Vanguard Health Care Inv | 5.84B | 0.29 | 3.64 | 6.36 | ||
T. Rowe Price Health Sciences I | 4.64B | -0.06 | 3.40 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 13.03 | 715.20 | -1.34% | |
UnitedHealth | US91324P1021 | 10.07 | 296.67 | -2.08% | |
Boston Scientific | US1011371077 | 4.75 | 104.50 | -0.13% | |
Merck&Co | US58933Y1055 | 3.94 | 77.84 | +1.12% | |
Intuitive Surgical | US46120E6023 | 3.39 | 542.67 | -0.80% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review